DEERFIELD, Ill. -
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced an increase in the company’s quarterly cash dividend, to a rate of $0.22 per share of common stock. This represents an approximately 16% increase over the previous quarterly dividend rate of $0.19 per share. Baxter’s Board of Directors declared the dividend payable on July 1, 2019, to stockholders of record as of June 7, 2019. The indicated annual dividend rate is now $0.88 per share of common stock.
“Baxter’s increased dividend reflects the ongoing impact of our business transformation, which is strengthening our financial position as we pursue our mission to save and sustain lives,” said José (Joe) E. Almeida, chairman and chief executive officer. “Our disciplined capital allocation strategy remains focused on driving innovation for patients, growth for the business and greater value for our investors.”
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.
Baxter is a registered trademark of Baxter International Inc.